Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1984-05-31
1990-09-25
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530389, 530390, 530391, 530808, 530412, 530413, 530813, 530815, 424 11, 424 858, 435 7021, 935108, 436547, 436529, 436531, 436548, 525541, 525542, C07K 1528, C07K 1702, C07K 312, C08H 100
Patent
active
049594575
ABSTRACT:
Antibody is provided which is capable of neutralizing the in vitro anti-neoplastic cellular activity of lymphotoxin. This antibody, which preferably is produced of monoclonal fusions, can be used in assays for lymphotoxin or for immunoaffinity purification of lymphotoxin.
REFERENCES:
patent: 4474754 (1984-10-01), Shimizu et al.
patent: 4481137 (1984-11-01), Ohnishi et al.
patent: 4513088 (1985-04-01), Levy et al.
patent: 4578335 (1986-03-01), Urdadn et al.
Sevier et al., Clin. Chem., 27, 1981, pp. 1797-1806.
Mizel et al., J. Immunol., 131, 1983, pp. 1834-1837.
Smith et al., J. Immunol., 131, 1983, pp. 1810-1815.
Chisholm, High Technology, 1983, pp. 57-63.
Vass et al., (eds.), Fluorescein Hapten: An Immunological Probe, CRC Press 1984.
Goding (ed.), Monoclonal Artibodies Principles and Practice AP, 1986.
Bio Rad Chromato., Electrophoresis, Immunochem, Mol. Bio., HPLC 1986.
Servier et al., Clin Chem. 27(11) 1981, pp. 1797-1806 (Review Article).
Synthetic Adjuvants, Adam, 1985, ed., (p. 150).
Modern Approaches to Vaccines, Chanock et al., 1984, ed., p. 248.
CA. No. 23146, vol. 81, 1974, "Mechanism of Cytoxicity of Soluble Factors from Lymphocytes", Walker et al.
Harris et al., "The Human LT Serum X. The Initial Form . . . Classes", J. Immunol, vol. 126(6), 1981, pp. 2165-2170.
Fair et al., "Release of LT Molecules . . . in Vitro", Mol. Immunol, vol. 16, 1979, pp. 185-192.
Yamamato et al., "Pharbolmyristate Arebule. . . In Virto", J. Biol. Resp. Modifiers, vol. 3, 1984, pp. 76-87.
Human T Cell Hybridoma Producing Lymphokines, Kobayashi et al., J. Immunol, 128(6), 1982, p. 2714.
Continuous Cultures of Fused Cells Secreting Antibody of Predetermined Specificity, Kohler et al., Nature, 256(5517), 1975, p. 495.
S. Fazekas de St. Groth et al., "J. Imm. Methods" 35:1-21, (1980).
Osebold, J. JAVMA, 181(10):983-987, (1982).
Edelman, R. Rev. Infectious Dis., 2(3):370-383, (1980).
Yamamoto et al., "Cellular Immunology" 38:403-416, (1978).
Gately et al., "Cellular Immunology" 27: 82-93, (1976).
Hiserodt et al., "J. of Immunology" 119(2): 374-380, (Aug. 1977).
Zacharchuk et al., "P.N.A.S. U.S.A." 80: 6341-6345, (Oct. 1983).
Mannel et al., "Infection and Immunity" 33(1): (Jul. 1981).
Wallach et al., DeMaeyer et al., Ed., "The Biology of the Interferon SYstem", pp. 293-302, (Pub. Sep. 1983).
Stone-Wolff et al., "J. Exp. Med." 159: 828-843, (Mar. 1984).
De Weck et al., Ed., "Biochemical Characterization of Lymphokines", pp. 279-312, (1980).
Ruddle et al., "Lymphokine Research" 2(1): 23-31, (1983).
Williamson et al., "P.N.A.S. U.S.A." 80: 5397-5401, (Sep. 1983).
Wright et al., "J. of Immunology" 126(4): 1516-1521, (Apr. 1981).
Papermaster et al., "Cancer" 45: 1248-1253, (1980).
Klostergaard et al., "Molecular Immunology" 18(12): 1049-1054, (1981).
Granger et al., "Lymphokine Research" 1(2): 45-49, (1982).
Adler Carolyn R.
Draper Garnette D.
Genentech Inc.
Hensley Max D.
LandOfFree
Anti-lymphotoxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-lymphotoxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-lymphotoxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-329719